Jan H. M. Schellens

Molecular Biology · 2000–2019

A researcher in the Science corpus: 10 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Jan H. M. Schellens trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Florian Maria Wurm

Papers from Jan H. M. Schellens's perspective

Ordered by how strongly the researchers Jan H. M. Schellens trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Potent antibody therapeutics by design (Nature reviews. Immunology)
  2. Antibody pharmacokinetics and pharmacodynamics. (Journal of Pharmacy and Science)
  3. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. (New England Journal of Medicine)
  4. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. (New England Journal of Medicine)
  5. Ovarian cancer: strategies for overcoming resistance to chemotherapy (Nature Reviews. Cancer)
  6. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. (Journal of the National Cancer Institute)
  7. Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors (EMBO Molecular Medicine)
  8. A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. (Journal of Clinical Oncology)
  9. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. (Journal of the National Cancer Institute)
  10. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR (Nature)

Their papers